DrugCentral: Online drug compendium

Nucleic Acids Research

Volumn 45, Issue D1, 2017, Pages D932-D939

  Ursu, Oleg ^a   Holmes, Jayme ^a   Knockel, Jeffrey ^b   Bologa, Cristian G ^a   Yang, Jeremy J ^a   Mathias, Stephen L ^a   Nelson, Stuart J ^a   Oprea, Tudor I ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

^b University of New Mexico   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL STRUCTURE; COMPUTER INTERFACE; DRUG APPROVAL; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG INDICATION; DRUG INDUSTRY; DRUG INFORMATION; DRUG INTERACTION; DRUG LABELING; DRUG MECHANISM; DRUG MONITORING; DRUG TARGETING; FOOD AND DRUG ADMINISTRATION; HUMAN; ONLINE SYSTEM; REFERENCE DATABASE; SOFTWARE; WEB BROWSER; CHEMISTRY; DRUG DATABASE; SEARCH ENGINE; UNITED STATES;

DATABASES, PHARMACEUTICAL; DRUG APPROVAL; DRUG COMPOUNDING; DRUG INTERACTIONS; DRUG LABELING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PHARMACEUTICAL PREPARATIONS; SEARCH ENGINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WEB BROWSER;

EID: 85016084712     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw993     Document Type: Article

References (29)

1. Bento, A.P., Gaulton, A., Hersey, A., Bellis, L.J., Chambers, J., Davies, M., Krüger, F.A., Light, Y., Mak, L., McGlinchey, S. et al. (2014) The ChEMBL bioactivity database: an update. Nucleic Acids Res., 42, D1083-D1090.
2. Southan, C., Sharman, J.L., Benson, H.E., Faccenda, E., Pawson, A.J., Alexander, S.P.H., Buneman, O.P., Davenport, A.P., McGrath, J.C., Peters, J.A. et al. (2016) The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res., 44, D1054-D1068.
3. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. and Tanabe, M. (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res., 40, D109-D114.
4. Nelson, S.J. (2009) Medical terminologies that work: the example of MeSH. 2009 10th International Symposium on Pervasive Systems, Algorithms, and Networks, Kaohsiung, 380-384.
5. Hastings, J., de Matos, P., Dekker, A., Ennis, M., Harsha, B., Kale, N., Muthukrishnan, V., Owen, G., Turner, S., Williams, M. et al. (2013) The ChEBI reference database and ontology for biologically relevant chemistry: enhancements for 2013. Nucleic Acids Res., 41, D456-D463.
6. Donnelly, K. (2006) SNOMED-CT: the advanced terminology and coding system for eHealth. Stud. Health Technol. Inform., 121, 279-290.
7. Bodenreider, O. (2004) The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res., 32, D267-D270.
8. Dalby, A., Nourse, J.G., Hounshell, W.D., Gushurst, A.K.I., Grier, D.L., Leland, B.A. and Laufer, J. (1992) Description of several chemical structure file formats used by computer programs developed at Molecular Design Limited. J. Chem. Inf. Comput. Sci., 32, 244-255.
9. CAS Registry System. (1978) CAS Registry System. J. Chem. Inf. Model., 18, 58-58.
10. Heller, S., McNaught, A., Stein, S., Tchekhovskoi, D., Pletnev, I., Wiswesser, W., Weininger, D., Dalby, A., Nourse, J., Hounshell, W. et al. (2013) InChI-the worldwide chemical structure identifier standard. J. Cheminform., 5, 7-16.
11. Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T. and Austin, C.P. (2011) The NCGC pharmaceutical collection: a comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Sci. Transl. Med., 3, 80ps16.
12. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V. et al. (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res., 42, D1091-D1097.
13. Legehar, A., Xhaard, H., Ghemtio, L., Bunnage, M., Hay, M., Thomas, D., Craighead, J., Economides, C., Rosenthal, J., Kola, I. et al. (2016) IDAAPM: integrated database of ADMET and adverse effects of predictive modeling based on FDA approved drug data. J. Cheminform., 8, 33-44.
14. Pihan, E., Colliandre, L., Guichou, J.-F. and Douguet, D. (2012) e-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design. Bioinformatics, 28, 1540-1541.
15. Lipinski, C.A., Lombardo, F., Dominy, B.W. and Feeney, P.J. (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 46, 3-26.
16. Oprea, T.I. (2000) Property distribution of drug-related chemical databases. J. Comput. Aided. Mol. Des., 14, 251-264.
17. Leo, A.J. (1993) Calculating log Poct from structures. Chem. Rev., 93, 1281-1306.
18. Oprea, T.I., Kim Nielsen, S., Ursu, O., Yang, J.J., Taboureau, O., Mathias, S.L., Kouskoumvekaki, I., Sklar, L.A. and Bologa, C.G. (2011) Associating drugs, targets and clinical outcomes into an integrated network affords a new platform for computer-aided drug repurposing. Mol. Inform., 30, 100-111.
19. Goede, A., Dunkel, M., Mester, N., Frommel, C. and Preissner, R. (2005) SuperDrug: a conformational drug database. Bioinformatics, 21, 1751-1753.
20. Hecker, N., Ahmed, J., von Eichborn, J., Dunkel, M., Macha, K., Eckert, A., Gilson, M.K., Bourne, P.E. and Preissner, R. (2012) SuperTarget goes quantitative: update on drug-target interactions. Nucleic Acids Res., 40, D1113-D1117.
21. Kuhn, M., Letunic, I., Jensen, L.J. and Bork, P. (2016) The SIDER database of drugs and side effects. Nucleic Acids Res., 44, D1075-D1079.
22. Santos, R., Ursu, O., Gaulton, A, Bento, A.P., Donadi, R.S., Bologa, C., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T.O. et al. (2017) A Comprehensive Map of Molecular Drug Targets. Nature Rev. Drug Discov., doi:10.1038/nrd.2016.230.
23. Ganter, B., Tugendreich, S., Pearson, C.I., Ayanoglu, E., Baumhueter, S., Bostian, K.A., Brady, L., Browne, L.J., Calvin, J.T., Day, G.-J. et al. (2005) Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J. Biotechnol., 119, 219-244.
24. Olah, M., Rad, R., Ostopovici, L., Bora, A., Hadaruga, N., Hadaruga, D., Moldovan, R., Fulias, A., Mractc, M. and Oprea, T.I. (2007) WOMBAT and WOMBAT-PK: bioactivity Databases for Lead and Drug Discovery. In: Chemical Biology. Wiley-VCH Verlag GmbH, Weinheim, pp. 760-786.
25. Roth, B.L., Lopez, E., Patel, S. and Kroeze, W.K. (2000) The multiplicity of serotonin receptors: uselessly diverse molecules or an embarrassment of riches? Neuroscientist, 6, 252-262.
26. Kibbe, W.A., Arze, C., Felix, V., Mitraka, E., Bolton, E., Fu, G., Mungall, C.J., Binder, J.X., Malone, J., Vasant, D. et al. (2015) Disease Ontology 2015 update: an expanded and updated database of human diseases for linking biomedical knowledge through disease data. Nucleic Acids Res., 43, D1071-D1078.
27. Huff, S.M., Rocha, R.A., McDonald, C.J., De Moor, G.J., Fiers, T., Bidgood, W.D., Forrey, A.W., Francis, W.G., Tracy, W.R., Leavelle, D. et al. Development of the Logical Observation Identifier Names and Codes (LOINC) vocabulary. J. Am. Med. Inform. Assoc., 5, 276-292.
28. Oprea, T.I., Bauman, J.E., Bologa, C.G., Buranda, T., Chigaev, A., Edwards, B.S., Jarvik, J.W., Gresham, H.D., Haynes, M.K., Hjelle, B. et al. (2011) Drug repurposing from an academic perspective. Drug Discov. Today Ther. Strateg., 8, 61-69.
29. Oprea, T.I. and Overington, J.P. (2015) Computational and practical aspects of drug repositioning. Assay Drug Dev. Technol., 13, 299-306.